SEC Form 4 · accession 0001638727-18-000003
Lexaria Bioscience Corp. · LXRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Martin Docherty
Officer — President · Director
Period of report
Jan 20, 2010
Accepted (ET)
Sep 4, 2018 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348362
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Aug 31, 2018 | A | 36,500 | $2.07 | A | 1,622,250 | I | Private holding company |
| Common Shares | holding | — | — | — | 1,585,750 | I | Private holding company |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $0.09 | holding | — | — | — | Mar 26, 2015 | Mar 26, 2020 | Common Shares | 550,000 | 550,000 | D |
| Stock Options | $0.11 | holding | — | — | — | Apr 15, 2016 | Apr 15, 2021 | Common Shares | 300,000 | 850,000 | D |
| Stock Options | $1.53 | holding | — | — | — | May 31, 2018 | May 31, 2023 | Common Shares | 400,000 | 1,250,000 | D |